CIK 0000811641
- Non-accelerated filer
- Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010382980
- Phone
- +1 207-878-2770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 3,845 shares (grant or award)
- 4 Grant or award Director acquired 4,742 shares (grant or award)
- 4 Open-market buy Director bought 2,000 shares at $4.00 ($8,000)
- 4 Open-market buy Director bought 4,600 shares at $4.28 ($19,688)
- 4 Open-market buy Director bought 5,130 shares at $4.98 ($25,547)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,724 shares (grant or award)
- 4 Grant or award Director acquired 4,269 shares (grant or award)
- 4 Option exercise President & CEO acquired 47,500 shares (option exercise)
- 4 Option exercise Vice President and CSO acquired 47,500 shares (option exercise)
- 4 Open-market buy Director bought 3,000 shares at $6.67 ($20,010)
- 4 Returned to the company Director returned 930 shares (to the company)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 13 · 256 filings